• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Reimbursement Top Challenge for Labs in 2025

Reimbursement Top Challenge for Labs in 2025

by Rachel Muenz | Jan 23, 2025 | Essential, Inside the Lab Industry-lir, Lab Industry Advisor

ACLA president Susan Van Meter discusses some of the key issues labs faced in 2024, along with work to address these developments through 2025

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FTC’s Ban of Noncompete Agreements Halted

FTC’s Ban of Noncompete Agreements Halted

by Tara Cepull, MA | Jan 10, 2025 | Essential, Lab Industry Advisor, Legislation-lca

With the rule recently struck down by a Texas court, how should employers, including labs, handle such agreements going forward?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Out with the Old: The 2024 Clinical Lab Experience

Out with the Old: The 2024 Clinical Lab Experience

by Oscelle Boye, MBiomed | Jan 7, 2025 | Essential, Inside the Lab Industry-lir, Lab Industry Advisor

What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?

FDA Watch: How Could the Change in US Government Affect IVDs and Labs?

by Rachel Muenz | Jan 6, 2025 | Essential, FDA-lir, Lab Industry Advisor

Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A Closer Lab-Patient Connection

A Closer Lab-Patient Connection

by Oscelle Boye, MBiomed | Dec 17, 2024 | Clinical Diagnostics Insider, Testing Trends-dtet

Patient access to data from the clinical lab is increasing. What does this mean for those generating it?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com